1. 1License Type and Order Details
  2. 2Payment Processing
  3. 3Order Confirmation
Secure Paymenthttps
Report BannerLung Cancer Market, By Type (Non-Small Cell Lung Cancer (NSCLC) (Adenocarcinoma, Squamous Cell Carcinoma, and Large Cell Carcinoma), Small Cell Lung Cancer (SCLC), and Lung Carcinoid Tumor), By Drug Class (Cytotoxic Chemotherapy (Alkylating agents (cisplatin, carboplatin, etc.), Antimetabolites (pemetrexed, gemcitabine), Mitotic inhibitors (taxanes: paclitaxel, docetaxel), Topoisomerase inhibitors (etoposide, irinotecan), and Others), Targeted Therapy (EGFR Inhibitors (Erlotinib, etc.), ALK Inhibitors (Crizotinib, etc.), ROS1 Inhibitors (Entrectinib, etc.), BRAF/MEK Inhibitors (Dabrafenib, etc.), MET Inhibitors (Capmatinib, etc.), RET Inhibitors (Selpercatinib, etc.), HER2 Inhibitors (Trastuzumab, etc.)), Immunotherapy, (PD-1 Inhibitors (Nivolumab, etc.), PD-L1 Inhibitors (Atezolizumab, etc.), CTLA-4 Inhibitors (Ipilimumab, etc.)), and Other Combination Therapeutics) and Other Combination Therapeutics), By Molecule Type (Small Molecules and Biologics), By Route of Administration (Parenteral and Oral), By Stage of Disease (Early-stage (Stage I–II), Locally Advanced (Stage III), and Metastatic/Advanced (Stage IV)), By Age Group (Adult, Pediatric, and Geriatric), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Diagnostic Laboratories, Specialty Cancer Clinics, Homecare Settings, and Others (Research and Academic Institutes, etc.)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2026-2033)

Select a License Type that Suits your Business Needs

Excel Databook

(Quantitative Data Only)

US$ 2,200
US$ 1,500

One Thousand Five Hundred Dollars

  • Dashboard with market estimates and forecasts
  • Raw Data Sheet providing cross-sectional analysis
  • Segments/taxonomy covered (Statistics)

PDF Report and Excel Databook (Both)

Single User License

(1 User)

US$ 4,500
US$ 3,500

Three Thousand Five Hundred Dollars

  • Report accessible to 1 user only (protected version to 1 user only)
  • PDF report + Raw Data Sheet providing cross-sectional analysis (Both Files)
  • Free 20% or 35 hours of customisation
  • Free post-sale service assistance
  • Direct access to lead analyst
Frequently Purchased

PDF Report and Excel Databook (Both)

Multi User License

(Upto 7 Users)

US$ 7,000
US$ 5,000

Five Thousand Dollars

  • Report accessible to 7 users (protected version to 7 users)
  • PDF report + Raw Data Sheet providing cross-sectional analysis (Both Files)
  • Free 30% or 70 hours of customisation
  • Free post-sale service assistance
  • Direct access to lead analysts
  • 25% discount on your next purchase
  • Dedicated account manager
  • Personalized market brief by the lead author, if needed
  • Printable version of the report

PDF Report and Excel Databook (Both)

Corporate User License

(Unlimited Users)

US$ 10,000
US$ 7,000

Seven Thousand Dollars

  • Report accessible to unlimited users (report transfer to unlimited users)
  • PDF report + Raw Data Sheet providing cross-sectional analysis (Both Files)
  • Free 35% or 85 hours of customisation
  • Free post-sale service assistance
  • Direct access to lead analysts
  • 100% Free - Next Year Version - Updated Report - (Free of Cost)
  • Dedicated account manager
  • Personalized market brief by the lead author, if needed
  • Printable version of the report